Genetic polymorphisms and chronic tarcolimus nephrotoxicity

XIE Ke-nan,CHEN Zhao-hong
DOI: https://doi.org/10.3969/j.issn.1006-298X.2012.06.016
2012-01-01
Abstract:Calcineurin inhibitor (CNI) is a mainstay of immunosuppressant agents for most solid organ transplant patients.Tacrolimus,which is widely used,has a narrow therapeutic range and its pharmacokinetic variability complicates its daily dose assessment.One of tacrolimus major side effect is nephrotoxicity.Several genes involve in the metabolism of tacrolimus,but whether the genetically polymorphisms play a role in tacrolimus chronic nephrotoxicity remains unknown.
What problem does this paper attempt to address?